CIK 0001745999
- Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-26 | Burrell Terry-Ann Chief Financial Officer | Grant or award | +12,500 | 82,637 | ||
| 2024-04-26 | Burrell Terry-Ann Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-04-01 | Burrell Terry-Ann Chief Financial Officer | Sale 10b5-1 | −5,446 | $32.12 | $175K | 70,137 |
| 2024-03-31 | Burrell Terry-Ann Chief Financial Officer | Grant or award | +27,500 | 75,583 | ||
| 2024-01-31 | Burrell Terry-Ann Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | $24.40 | $1.3M | 55,000 |
| 2023-04-04 | Burrell Terry-Ann Chief Financial Officer | Sale 10b5-1 | −2,186 | $29.09 | $64K | 47,117 |
| 2023-04-03 | Burrell Terry-Ann Chief Financial Officer | Sale 10b5-1 | −2,454 | $30.31 | $74K | 49,303 |
| 2023-03-31 | Burrell Terry-Ann Chief Financial Officer | Grant or award | +20,000 | 51,277 | ||
| 2023-01-31 | Burrell Terry-Ann Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-01-31 | Burrell Terry-Ann Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-01-27 | Burrell Terry-Ann Chief Financial Officer | Exercise or conversion | +36,152 | $13.68 | $495K | 67,429 |
| 2023-01-27 | Burrell Terry-Ann Chief Financial Officer | Sale | −36,152 | $45.08 | $1.6M | 31,277 |
| 2023-01-27 | Burrell Terry-Ann Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −36,152 | 185,565 | ||
| 2023-01-26 | Burrell Terry-Ann Chief Financial Officer | Exercise or conversion | +1,102 | $13.68 | $15K | 32,379 |
| 2023-01-26 | Burrell Terry-Ann Chief Financial Officer | Sale | −1,102 | $45.16 | $50K | 31,277 |
| 2023-01-26 | Burrell Terry-Ann Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −1,102 | 221,717 | ||
| 2023-01-24 | Burrell Terry-Ann Chief Financial Officer | Exercise or conversion | +14,810 | $13.68 | $203K | 46,087 |
| 2023-01-24 | Burrell Terry-Ann Chief Financial Officer | Sale | −14,810 | $45.01 | $667K | 31,277 |
| 2023-01-24 | Burrell Terry-Ann Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −14,810 | 222,819 | ||
| 2023-01-23 | Burrell Terry-Ann Chief Financial Officer | Exercise or conversion | +5,426 | $13.68 | $74K | 36,703 |
Page 1 of 3 · 54 trades